Patents by Inventor Ian Gibbons

Ian Gibbons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10392650
    Abstract: Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable product at distinct rates. The detectable product is measured at different times after assay initiation. A lipase, cholesterol esterase, cholesterol oxidase and a peroxidase may be used together to produce colored product in amounts directly proportional to the quantity of cholesterol converted. Methods for calculating very-low density lipoprotein cholesterol levels by further including triglyceride measurements are disclosed.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: August 27, 2019
    Assignee: Theranos IP Company, LLC
    Inventors: Douglas Matje, Ian Gibbons, Paul Patel, Elizabeth A. Holmes
  • Publication number: 20190185232
    Abstract: The present disclosure describes bottle closure assemblies which are made at least in part with a high density unimodal polyethylene. The bottle closure assembly includes a cap portion, an elongated tether portion and a retaining means portion. The retaining means portions engages a bottle neck or an upper portion of a bottle. The elongated tether portion connects at least one point on the cap portion to at least one point on the retaining means portion so as to prevent loss of the cap portion from a bottle.
    Type: Application
    Filed: December 11, 2018
    Publication date: June 20, 2019
    Applicant: NOVA Chemicals (International) S.A.
    Inventors: XiaoChuan Wang, Ian Gibbons, Eric Vignola, Cliff Baar, Amin Mirzadeh
  • Publication number: 20190185219
    Abstract: The present disclosure describes bottle closure assemblies which are made at least in part with a polyethylene copolymer having good organoleptic properties. The bottle closure assembly includes a cap portion, an elongated tether portion, and a retaining means portion. The retaining means portions engages a bottle neck or an upper portion of a bottle. The elongated tether portion connects at least one point on the cap portion to at least one point on the retaining means portion so as to prevent loss of the cap portion from a bottle.
    Type: Application
    Filed: December 14, 2018
    Publication date: June 20, 2019
    Applicant: NOVA Chemicals (International) S.A.
    Inventors: XiaoChuan Wang, Ian Gibbons, Eric Vignola, Cliff Baar, Amin Mirzadeh
  • Publication number: 20190185233
    Abstract: The present disclosure describes bottle closure assemblies which are made at least in part with a polyethylene homopolymer composition. The bottle closure assembly includes a cap portion, an elongated tether portion, and a retaining means portion. The retaining means portions engages a bottle neck or an upper portion of a bottle. The elongated tether portion connects at least one point on the cap portion to at least one point on the retaining means portion so as to prevent loss of the cap portion from a bottle.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Applicant: NOVA Chemicals (International) S.A.
    Inventors: XiaoChuan Wang, Ian Gibbons, Eric Vignola, Cliff Baar, Amin Mirzadeh
  • Publication number: 20190168935
    Abstract: The present disclosure describes bottle closure assemblies which are made at least in part with a polyethylene composition having good processability, good organoleptic properties and good dimensional stability. The bottle closure assembly includes a cap portion, an elongated tether portion, and a retaining means portion. The retaining means portions engages a bottle neck or an upper portion of a bottle. The elongated tether portion connects at least one point on the cap portion to at least one point on the retaining means portion so as to prevent loss of the cap portion from a bottle.
    Type: Application
    Filed: November 28, 2018
    Publication date: June 6, 2019
    Applicant: NOVA Chemicals (International) S.A.
    Inventors: XiaoChuan Wang, Ian Gibbons, Eric Vignola, Cliff Baar, Amin Mirzadeh
  • Publication number: 20190168936
    Abstract: The present disclosure describes bottle closure assemblies which are made at least in part with a polyethylene composition having good flow properties and good resistance to environmentally induced stress cracking. The bottle closure assembly includes a cap portion, an elongated tether portion, and a retaining means portion. The retaining means portions engages a bottle neck or an upper portion of a bottle. The elongated tether portion connects at least one point on the cap portion to at least one point on the retaining means portion so as to prevent loss of the cap portion from a bottle.
    Type: Application
    Filed: December 4, 2018
    Publication date: June 6, 2019
    Applicant: NOVA Chemicals (International) S.A.
    Inventors: XiaoChuan Wang, Ian Gibbons, Eric Vignola, Cliff Baar, Amin Mirzadeh
  • Patent number: 10281479
    Abstract: Methods, compositions, systems, and devices are provided for performing and analyzing agglutination assays. In one aspect, methods for image analysis of agglutination assays are provided. In another aspects, methods for performing agglutination assays are provided. In one aspect, the methods may be used for the detection of various molecules, including viruses or antibodies against a virus. In another aspect, the methods can be used to determine effective immunization of a subject.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: May 7, 2019
    Assignee: Theranos IP Company, LLC
    Inventors: Paul Patel, Samartha Anekal, Ian Gibbons, Elizabeth A. Holmes, Swapna Joshi
  • Publication number: 20190128902
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Application
    Filed: December 17, 2018
    Publication date: May 2, 2019
    Inventors: Ian GIBBONS, Shaunak ROY, Edmond KU
  • Publication number: 20180374582
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: April 13, 2018
    Publication date: December 27, 2018
    Applicant: Theranos IP Company, LLC
    Inventors: Elizabeth A. HOLMES, Ian GIBBONS, Daniel YOUNG, Seth G. MICHELSON
  • Patent number: 10156579
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: December 18, 2018
    Assignee: Theranos IP Company, LLC
    Inventors: Ian Gibbons, Shaunak Roy, Edmond Ku
  • Publication number: 20180308585
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Application
    Filed: April 13, 2018
    Publication date: October 25, 2018
    Applicant: Theranos IP Company, LLC
    Inventors: Elizabeth A. HOLMES, Ian GIBBONS, Daniel YOUNG, Seth G. MICHELSON
  • Patent number: 10067123
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: September 4, 2018
    Assignee: Theranos IP Company LLC
    Inventors: Ian Gibbons, Michael O'Connell
  • Publication number: 20180238864
    Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
    Type: Application
    Filed: April 13, 2018
    Publication date: August 23, 2018
    Inventors: Tammy BURD, Ian GIBBONS, Elizabeth A. HOLMES, Gary FRENZEL, Anthony Joseph NUGENT
  • Publication number: 20180231536
    Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
    Type: Application
    Filed: April 13, 2018
    Publication date: August 16, 2018
    Inventors: Tammy BURD, Ian GIBBONS, Elizabeth A. HOLMES, Gary FRENZEL, Anthony Joseph NUGENT
  • Publication number: 20180231534
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.
    Type: Application
    Filed: April 12, 2018
    Publication date: August 16, 2018
    Inventors: Ian Gibbons, Michael O'connell
  • Publication number: 20180231469
    Abstract: The present invention provides methods of calibrating a fluidic device useful for detecting an analyte of interest in a bodily fluid. The invention also provides methods for assessing the reliability of an assay for an analyte in a bodily fluid with the use of a fluidic device. Another aspect of the invention is a method for performing a trend analysis on the concentration of an analyte in a subject using a fluidic device.
    Type: Application
    Filed: April 12, 2018
    Publication date: August 16, 2018
    Inventors: Ian GIBBONS, Chengwang WANG, Shaunak Roy, Elizabeth A. Holmes
  • Publication number: 20180231533
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Application
    Filed: April 12, 2018
    Publication date: August 16, 2018
    Inventors: Elizabeth A. HOLMES, Shaunak Roy, Ian Gibbons, Shize Daniel Qi, Edmond Ku, Chris Todd, Melissa Takahashi, Bruce Johnson, Jeff Fenton, Keith Moravick, Uwe Springborn, Anthony Delacruz
  • Publication number: 20180231535
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.
    Type: Application
    Filed: April 12, 2018
    Publication date: August 16, 2018
    Inventors: Ian Gibbons, Michael O'CONNELL
  • Publication number: 20180209976
    Abstract: The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.
    Type: Application
    Filed: January 8, 2018
    Publication date: July 26, 2018
    Inventors: Elizabeth A. Holmes, Ian Gibbons
  • Patent number: 9885715
    Abstract: The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.
    Type: Grant
    Filed: January 14, 2014
    Date of Patent: February 6, 2018
    Assignee: Theranos IP Comany, LLC
    Inventors: Elizabeth A. Holmes, Ian Gibbons